OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
March 28, 2019
The company has launched a comprehensive portfolio of custom cell biology solutions and a new cell-line engineering technology.
March 26, 2019
Belgium-based CDMO MaSTherCell will expand its European manufacturing capacity for cell and gene therapy products by setting up a new facility in Belgium.
March 25, 2019
A $1.7-billion acquisition CDMO Brammer Bio establishes Thermo Fisher Scientific in viral vector manufacturing.
March 20, 2019
Think ahead to production requirements when planning strategies in early development of gene and cell therapies.
The companies aim to assess automated CAR-T cell therapy manufacturing at the point-of-care and develop technologies to facilitate patient access to immunotherapies.
The Pharma Services business of Thermo Fisher Scientific will invest $150 Million at three facilities.
Alcami Biologics formed to meet market demands for biological drug development services.
Catalent announces investment for its Zydis ODT technology, offering increased drug load and taste-masking capabilities.
March 12, 2019
The acquisition of the site in Copenhagen, Denmark, will significantly expand Fujifilm’s capacity and capabilities.
March 11, 2019
Process optimization improves process mass intensity, reduces environmental impact, and improves cycle time for bio/pharmaceutical processes.